Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Showing 1–4 of 4 articles · Keyword: angiogenesis Clear keyword

Iranian Polymer Journal2021ReviewDrug Delivery

1. Current progress of self‑healing polymers for medical applications in tissue engineering

Self-healing polymers can repair damage and recover functionality, potentially extending the lifetime and safety of biomedical devices. Although self-healing hydrogels have been reviewed previously, papers focused specifically on their use in tissue engineering are scarce. This review summarises fabrication methods…

Read the article
Advanced Drug Delivery Reviews2016ReviewNon-viral Gene Delivery

2. Gene Delivery Nanoparticles to Modulate Angiogenesis

Jayoung Kim, Adam C. Mirando, Aleksander S. Popel, Jordan J. Green

Angiogenesis is normally balanced by pro- and anti-angiogenic factors, but imbalance leads to aberrant angiogenesis in ischaemia, tissue regeneration, cancer, and neovascular age-related macular degeneration (wet AMD). Gene therapy is a promising strategy to introduce exogenous nucleic acids that express or silence…

Read the article
Advanced Drug Delivery Reviews2015ReviewNon-viral Gene Delivery

3. In Vivo Delivery of miRNAs for Cancer Therapy: Challenges and Strategies

Yunching Chen, Dong-Yu Gao, Leaf Huang

miRNAs can simultaneously regulate multiple cancer-related genes, making them attractive therapeutic agents or targets. However, efficient, specific, and safe systemic delivery of therapeutic miRNAs in vivo remains a major challenge due to rapid degradation, poor tumour penetration, immunotoxicity, endosomal…

Read the article
Current Opinion in Lipidology2012ReviewNon-viral Gene Delivery

4. Lipid-based carriers of microRNAs and intercellular communication

Vickers Kc, Remaley At

Extracellular miRNAs are unusually stable in plasma and their circulating levels change with disease, making them promising biomarkers. They are associated with lipid-based carriers—exosomes, microvesicles, apoptotic bodies, and lipoproteins—as well as lipid-free proteins. Whether these carriers mediate functional…

Read the article
Articles | Brilliant Blue Biosciences